TCRT
$3.12
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders.
Intraday
Recent News
Ziopharm: Q3 Earnings Snapshot
HOUSTON (AP) — Alaunos Therapeutics, Inc. TCRT) on Friday reported a loss of $1.2 million in its third quarter. The Houston-based company said it had a loss of 55 cents per share.
Ziopharm: Q2 Earnings Snapshot
HOUSTON (AP) — Alaunos Therapeutics, Inc. TCRT) on Thursday reported a loss of $1.1 million in its second quarter. On a per-share basis, the Houston-based company said it had a loss of 63 cents.
Alaunos Therapeutics And 2 Other Promising Penny Stocks To Watch
Amidst a turbulent market backdrop, where major indices like the Dow Jones and Nasdaq Composite have faced significant declines due to escalating trade tensions, investors are increasingly seeking alternative opportunities. Penny stocks, often representing smaller or newer companies, continue to hold allure for those looking beyond traditional large-cap investments. Despite being an older term, they offer potential growth when backed by solid financials; this article explores three such...